Remington-Davis Clinical Research   Report issue

For profit Phase 2
Founded: Columbus OH United States (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2004
NCT00417872
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Remington-Davis Inc., and Riverside Infection Consultants, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 2)

Colitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4